Women's Hormone + PCOS Panel

Irregular periods, acne that won't quit, hair where you don't want it, weight that clings to your midsection. These symptoms send millions of women through years of frustration before anyone connects the dots. Polycystic ovary syndrome (PCOS) affects between 8% and 13% of women of reproductive age worldwide, and up to 70% of those affected remain undiagnosed. The reason is simple: no single test confirms it, and a standard checkup rarely looks at the right combination of markers.

This panel pulls together the hormones that govern your menstrual cycle, the androgens (male-pattern hormones that every woman produces in small amounts) that drive many PCOS symptoms, the metabolic markers that reveal hidden insulin and blood sugar problems, and the lipid profile that tracks cardiovascular risk. Ordering them together, from one blood draw, gives you a clinical picture that piecemeal testing almost always misses.

What This Panel Reveals

The tests in this panel cover three overlapping clinical domains: reproductive hormone balance, androgen excess, and metabolic health. PCOS sits at the intersection of all three, which is why checking just one domain leaves you with an incomplete answer.

Reproductive Hormone Balance

Your brain's pituitary gland sends two signaling hormones to your ovaries: luteinizing hormone (LH) and follicle-stimulating hormone (FSH). In a typical cycle, FSH rises first to mature an egg, then LH surges to trigger ovulation. In PCOS, LH is often persistently elevated while FSH stays low or normal, creating a ratio that disrupts follicle development and stalls ovulation.

Estradiol, the primary form of estrogen, reflects ovarian activity. Progesterone rises after ovulation and stays low if ovulation didn't happen. Together, these four hormones tell you whether your cycle is actually cycling or just bleeding on a rough schedule. Prolactin and thyroid markers (TSH, or thyroid-stimulating hormone, and Free T4) are included because elevated prolactin and thyroid dysfunction can both mimic PCOS symptoms, and guidelines recommend ruling them out before settling on a PCOS diagnosis.

Androgen Excess

Excess androgens cause many of the visible symptoms of PCOS: jawline acne, thinning scalp hair, and excess facial or body hair (called hirsutism). Total testosterone measures the full amount circulating in your blood, but most of it is bound to a carrier protein called sex hormone binding globulin (SHBG) and is inactive. Free testosterone, the unbound fraction, is what actually reaches tissues and drives symptoms.

SHBG levels tend to drop when insulin is high, which frees up more testosterone. This is why a woman's total testosterone can look normal while her free testosterone is elevated. A 2007 Endocrine Society position statement in the Journal of Clinical Endocrinology and Metabolism established that calculated free testosterone has higher sensitivity for detecting androgen excess in PCOS than total testosterone alone. Measuring all three markers together, total testosterone, free testosterone, and SHBG, catches androgen excess that either marker alone would miss.

Metabolic and Cardiovascular Health

PCOS is not just a reproductive condition. Between 50% and 70% of women with PCOS have insulin resistance, regardless of body weight. The metabolic markers in this panel, insulin, glucose, and HbA1c (a measure of average blood sugar over roughly three months), reveal whether your body is struggling to process sugar even when fasting glucose still looks normal. Insulin often rises years before glucose does, making it the earliest warning signal.

The lipid markers round out the metabolic picture. Women with PCOS have roughly double the odds of having an unfavorable lipid pattern compared to women without the condition, according to a meta-analysis published in Fertility and Sterility. The typical pattern is elevated triglycerides and low HDL, a combination that independently raises cardiovascular risk. LDL and total cholesterol complete the profile and help determine whether treatment should target lipids alongside hormones.

Albumin is included as a binding protein reference. It carries hormones and drugs through the blood, and its level affects the accuracy of free testosterone calculations. Low albumin can also signal nutritional deficiency or liver issues that change how your body handles hormones.

How to Read Your Results Together

Individual results matter, but the patterns across results tell the real story. Here are the most common patterns and what they point to.

A low progesterone level (typically below 3 ng/mL in the mid-luteal phase, roughly days 19 to 22 of a 28-day cycle) strongly suggests you did not ovulate that cycle. If LH and free testosterone are also in the PCOS pattern, the lack of ovulation is likely hormonal rather than structural.

When Results Can Be Misleading

Timing matters more for this panel than for most blood tests. Reproductive hormones shift dramatically across the menstrual cycle. LH, FSH, and estradiol are typically drawn on days 2 through 5 of your cycle (counting from the first day of your period) to capture baseline values. Progesterone is most informative at mid-luteal phase, about 7 days after expected ovulation. If your cycles are very irregular or absent, your provider may draw everything at once and interpret accordingly.

Hormonal contraceptives suppress your natural hormone production and will mask PCOS patterns. Most guidelines recommend stopping hormonal birth control for at least three months before testing, though this should be discussed with your provider. Biotin supplements can interfere with the laboratory methods used to measure several of these tests, including TSH and testosterone. Stop biotin at least 72 hours before your blood draw.

Acute stress, illness, extreme caloric restriction, and intense exercise can all suppress LH and FSH, mimicking a different hormonal picture. A single set of results during a period of high stress may not reflect your true baseline.

Tracking Over Time

A single snapshot of your hormones tells you where things stand today. Serial testing, repeating this panel every 6 to 12 months, reveals whether your interventions are working and whether your metabolic risk is changing. Insulin resistance often responds to dietary changes, exercise, or medication within three to six months, and watching insulin and triglycerides trend downward confirms you're on the right track.

SHBG is a particularly useful tracking marker. As insulin resistance improves, SHBG typically rises, which means less free testosterone and fewer androgen-driven symptoms. Watching SHBG climb over successive panels gives you a tangible signal that the metabolic root of your symptoms is shifting.

For women trying to conceive, serial progesterone measurements across cycles can confirm whether ovulation is occurring. For those managing PCOS long-term, annual lipid and metabolic checks catch cardiovascular drift early, when lifestyle adjustments can still reverse it.

What to Do with Your Results

If your results show a clear PCOS hormonal pattern (elevated androgens, disrupted LH/FSH, no ovulation), the next step is to evaluate the metabolic side. An elevated insulin with normal glucose means insulin resistance is already present but hasn't yet pushed blood sugar out of range. This is the window where intervention has the most impact.

If your lipid panel shows high triglycerides with low HDL, that pattern warrants attention even if LDL looks fine. In women with PCOS, this lipid profile is associated with increased cardiovascular risk over the following decades, according to long-term follow-up data from the Coronary Artery Risk Development in Young Adults (CARDIA) study.

An elevated TSH or prolactin shifts the clinical picture entirely. Thyroid dysfunction is treatable and may resolve cycle irregularities on its own. Elevated prolactin may require imaging to rule out a prolactinoma, a small, usually benign pituitary tumor. Address these findings before attributing symptoms to PCOS.

Consider adding an anti-Mullerian hormone (AMH) test if PCOS is suspected but the hormonal pattern is borderline. AMH reflects the pool of small follicles in the ovaries and is elevated in most women with PCOS. For metabolic follow-up, a formal insulin resistance score (HOMA-IR) can be calculated from your fasting insulin and glucose results. If you are concerned about long-term cardiovascular risk, an ApoB (apolipoprotein B) or lipoprotein(a) test adds particle-level detail beyond standard cholesterol numbers.